Nashville, TN 的 骨髓纖維化 臨床試驗
9 項針對 骨髓纖維化 的研究正在 Nashville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
招募中1/2 期
- Tri-Star Centennial Medical Center, Nashville
- Vanderbilt University, Nashville
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
招募中3 期
- Vanderbilt-Ingram Cancer Center (VICC)-Nashville, Nashville
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
招募中1 期
- Tennessee Oncology, PLLC - Investigational Drug Services, Nashville
- Tristar BMT, Nashville
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
招募中2 期
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
招募中1 期
- Tristar Bmt/Tcto, Nashville
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
招募中2 期
- GSK Investigational Site, Nashville
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
招募中1 期
- Vanderbilt University Medical Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Nashville
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
招募中3 期
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
其他城市的 骨髓纖維化 試驗
- Houston, TX19 項研究
- New York City, NY18 項研究
- Boston, MA12 項研究
- Durham, NC12 項研究
- Seattle, WA11 項研究
- Columbus, OH11 項研究
- Salt Lake City, UT10 項研究
- Miami, FL10 項研究
- Baldwin Park, CA9 項研究
- Atlanta, GA9 項研究
- Tampa, FL9 項研究
- Cleveland, OH9 項研究
Nashville 的其他研究
- 非小細胞肺癌97 項研究
- 乳癌81 項研究
- 轉移性癌症70 項研究
- 大腸直腸癌69 項研究
- 癌症（所有類型）65 項研究
- 卵巢癌49 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 頭頸部鱗狀細胞癌39 項研究
- 胰臟癌39 項研究
- 子宮內膜癌38 項研究
- 黑色素瘤33 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。